{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T15:22:18Z","timestamp":1790954538064,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3R37AI080289-11S1"],"award-info":[{"award-number":["3R37AI080289-11S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CIVIC75N93019C00052"],"award-info":[{"award-number":["CIVIC75N93019C00052"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01OD026529"],"award-info":[{"award-number":["K01OD026529"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI158571"],"award-info":[{"award-number":["P01AI158571"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI165072"],"award-info":[{"award-number":["P01AI165072"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI146785"],"award-info":[{"award-number":["R01AI146785"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA260476 \u2013 01"],"award-info":[{"award-number":["U01CA260476 \u2013 01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI135995-02"],"award-info":[{"award-number":["U19AI135995-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI42790-01"],"award-info":[{"award-number":["U19AI42790-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54 CA260543"],"award-info":[{"award-number":["U54 CA260543"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019480","name":"North Carolina General Assembly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.celrep.2023.112326","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T19:13:27Z","timestamp":1680203607000},"page":"112326","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7780-9973","authenticated-orcid":false,"given":"Lily E.","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Leist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Kenneth H.","family":"Dinnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ande","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kendra L.","family":"Gully","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F.","family":"Loome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabella N.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny S.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry L.","family":"Bertera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Zweigart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn S.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brea K.","family":"Hampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmanane","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria K.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph S.","family":"Baric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2023.112326_bib1","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112326_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112326_bib3","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1073\/pnas.1517719113","article-title":"SARS-like WIV1-CoV poised for human emergence","volume":"113","author":"Menachery","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112326_bib4","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/nm.3985","article-title":"A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence","volume":"21","author":"Menachery","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2023.112326_bib5","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1073\/pnas.0506735102","article-title":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats","volume":"102","author":"Lau","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112326_bib6","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112326_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41586-022-04532-4","article-title":"Bat coronaviruses related to SARS-CoV-2 and infectious for human cells","volume":"604","author":"Temmam","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112326_bib8","doi-asserted-by":"crossref","first-page":"166725","DOI":"10.1016\/j.jmb.2020.11.024","article-title":"Structural insights into SARS-CoV-2 proteins","volume":"433","author":"Arya","year":"2021","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.celrep.2023.112326_bib9","doi-asserted-by":"crossref","first-page":"e03149-20","DOI":"10.1128\/mBio.03149-20","article-title":"Critical ACE2 determinants of SARS-CoV-2 and group 2B coronavirus infection and replication","volume":"12","author":"Adams","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2023.112326_bib10","doi-asserted-by":"crossref","first-page":"e00127-20","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112326_bib11","doi-asserted-by":"crossref","first-page":"19944","DOI":"10.1073\/pnas.0808116105","article-title":"Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice","volume":"105","author":"Becker","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112326_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","article-title":"SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness","volume":"586","author":"Corbett","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112326_bib13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1126\/science.abi4506","article-title":"Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice","volume":"373","author":"Martinez","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112326_bib14","doi-asserted-by":"crossref","first-page":"100451","DOI":"10.1016\/j.imu.2020.100451","article-title":"Leaving no stone unturned: allosteric targeting of SARS-CoV-2 spike protein at putative druggable sites disrupts human angiotensin-converting enzyme interactions at the receptor binding domain","volume":"21","author":"Olotu","year":"2020","journal-title":"Inform. Med. Unlocked"},{"key":"10.1016\/j.celrep.2023.112326_bib15","doi-asserted-by":"crossref","first-page":"e75433","DOI":"10.7554\/eLife.75433","article-title":"Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike","volume":"11","author":"D\u00edaz-Salinas","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2023.112326_bib16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cell.2020.06.011","article-title":"A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies","volume":"182","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112326_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.abd3871","article-title":"Selective and cross-reactive SARS-CoV-2 T\u00a0cell epitopes in unexposed humans","volume":"370","author":"Mateus","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112326_bib18","doi-asserted-by":"crossref","first-page":"eabc9999","DOI":"10.1126\/sciadv.abc9999","article-title":"Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals","volume":"6","author":"Zhu","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2023.112326_bib19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41591-021-01270-4","article-title":"Neutralization of SARS-CoV-2 spike 69\/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera","volume":"27","author":"Xie","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2023.112326_bib20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.abf4830","article-title":"Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody","volume":"371","author":"Rappazzo","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112326_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41590-020-00808-x","article-title":"SARS-CoV-2 T-Cell Epitopes Define Heterologous and COVID-19-Induced T-Cell Recognition","volume":"22","author":"Nelde","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2023.112326_bib22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112326_bib23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112326_bib24","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1016\/j.cell.2021.06.021","article-title":"In\u00a0vitro and in\u00a0vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies","volume":"184","author":"Li","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112326_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-med-042420-113838","article-title":"SARS-CoV-2 neutralizing antibodies for COVID-19 prevention and treatment","volume":"73","author":"Li","year":"2022","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.celrep.2023.112326_bib26","doi-asserted-by":"crossref","first-page":"14216","DOI":"10.1073\/pnas.1111497108","article-title":"Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin","volume":"108","author":"Whittle","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112326_bib27","article-title":"Conserved neutralizing epitopes on the N-terminal domain of variant SARS-CoV-2 spike proteins","author":"Wang","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2023.112326_bib28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.abh2315","article-title":"Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: a global consortium study","volume":"374","author":"Hastie","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112326_bib29","doi-asserted-by":"crossref","first-page":"eabj7125","DOI":"10.1126\/scitranslmed.abj7125","article-title":"A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice","volume":"14","author":"Martinez","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2023.112326_bib30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-021-04017-w","article-title":"Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy","volume":"599","author":"Yamin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112326_bib31","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.chom.2021.06.001","article-title":"A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T\u00a0cell responses","volume":"29","author":"Tauzin","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112326_bib32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41591-021-01263-3","article-title":"Humoral signatures of protective and pathological SARS-CoV-2 infection in children","volume":"27","author":"Bartsch","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2023.112326_bib33","doi-asserted-by":"crossref","first-page":"e0253487","DOI":"10.1371\/journal.pone.0253487","article-title":"The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody","volume":"16","author":"Chan","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112326_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.immuni.2022.01.001","article-title":"mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern","volume":"55","author":"Kaplonek","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112326_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.celrep.2023.112326_bib36","doi-asserted-by":"crossref","first-page":"e00027-18","DOI":"10.1128\/JVI.00027-18","article-title":"Development of a broadly accessible Venezuelan equine encephalitis virus replicon particle vaccine platform","volume":"92","author":"Agnihothram","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112326_bib37","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1371\/journal.pmed.0030525","article-title":"Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants","volume":"3","author":"Deming","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.celrep.2023.112326_bib38","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","article-title":"A mouse-adapted SARS-CoV-2 induces acute lung injury (ALI) and mortality in standard laboratory mice","volume":"183","author":"Leist","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112326_bib39","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41586-020-2708-8","article-title":"A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures","volume":"586","author":"Dinnon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2023.112326_bib40","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.cell.2015.10.027","article-title":"Dissecting polyclonal vaccine-induced humoral immunity against HIV using systems serology","volume":"163","author":"Chung","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112326_bib41","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41564-020-0771-4","article-title":"Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic","volume":"5","author":"Boni","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2023.112326_bib42","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.cell.2020.09.050","article-title":"A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice","volume":"183","author":"Leist","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112326_bib43","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.immuni.2021.06.018","article-title":"COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge","volume":"54","author":"DiPiazza","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112326_bib44","doi-asserted-by":"crossref","first-page":"e0131451","DOI":"10.1371\/journal.pone.0131451","article-title":"New metrics for evaluating viral respiratory pathogenesis","volume":"10","author":"Menachery","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112326_bib45","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1038\/s41598-022-10230-y","article-title":"Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination","volume":"12","author":"Geanes","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2023.112326_bib46","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41467-021-21968-w","article-title":"A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2023.112326_bib47","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112326_bib48","article-title":"Isolation of bat sarbecoviruses of SARS-CoV-2 clade, Japan","author":"Murakami","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2023.112326_bib49","doi-asserted-by":"crossref","first-page":"e0145422","DOI":"10.1128\/mbio.01454-22","article-title":"A multitrait locus regulates sarbecovirus pathogenesis","volume":"13","author":"Sch\u00e4fer","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2023.112326_bib50","doi-asserted-by":"crossref","first-page":"101495","DOI":"10.1016\/j.trim.2021.101495","article-title":"T helper type (Th1\/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: from cytokines produced to immune responses","volume":"70","author":"Aleebrahim-Dehkordi","year":"2022","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.celrep.2023.112326_bib51","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/s41591-018-0161-0","article-title":"Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV","volume":"24","author":"Ackerman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2023.112326_bib52","doi-asserted-by":"crossref","first-page":"112630","DOI":"10.1016\/j.jim.2019.07.002","article-title":"A high-throughput, bead-based, antigen-specific assay to assess the ability of antibodies to induce complement activation","volume":"473","author":"Fischinger","year":"2019","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.celrep.2023.112326_bib53","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.abj4176","article-title":"Durability of mRNA-1273 vaccine\u2013induced antibodies against SARS-CoV-2 variants","volume":"373","author":"Pegu","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112326_bib54","doi-asserted-by":"crossref","first-page":"e2226335","DOI":"10.1001\/jamanetworkopen.2022.26335","article-title":"Durability of heterologous and homologous COVID-19 vaccine boosts","volume":"5","author":"Tan","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.celrep.2023.112326_bib55","doi-asserted-by":"crossref","first-page":"eabn9243","DOI":"10.1126\/scitranslmed.abn9243","article-title":"Omicron variant Spike-specific antibody binding and Fc activity are preserved in recipients of mRNA or inactivated COVID-19 vaccines","volume":"14","author":"Bartsch","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2023.112326_bib56","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.immuni.2021.05.001","article-title":"Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets","volume":"54","author":"Dugan","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112326_bib57","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/jvi.70.6.3781-3787.1996","article-title":"A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge","volume":"70","author":"Davis","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112326_bib58","doi-asserted-by":"crossref","first-page":"13710","DOI":"10.1128\/JVI.01351-07","article-title":"Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats","volume":"81","author":"Mok","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112326_bib59","doi-asserted-by":"crossref","first-page":"e75537","DOI":"10.7554\/eLife.75537","article-title":"SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern","volume":"11","author":"Hawman","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2023.112326_bib60","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.omtm.2022.03.013","article-title":"Self-amplifying mRNA SARS-CoV-2 vaccines raise cross-reactive immune response to variants and prevent infection in animal models","volume":"25","author":"Palladino","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.celrep.2023.112326_bib61","doi-asserted-by":"crossref","first-page":"eabc9396","DOI":"10.1126\/scitranslmed.abc9396","article-title":"An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T\u00a0cell responses in mice and nonhuman primates","volume":"12","author":"Erasmus","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2023.112326_bib62","doi-asserted-by":"crossref","first-page":"eabi9915","DOI":"10.1126\/scitranslmed.abi9915","article-title":"Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection","volume":"13","author":"Greaney","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2023.112326_bib63","doi-asserted-by":"crossref","first-page":"671633","DOI":"10.3389\/fmolb.2021.671633","article-title":"Antibodies and vaccines target RBD of SARS-CoV-2","volume":"8","author":"Min","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.celrep.2023.112326_bib64","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.abg5268","article-title":"Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes","volume":"372","author":"Voss","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112326_bib65","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.4049\/jimmunol.2001438","article-title":"Genome-wide B cell, CD4+, and CD8+ T\u00a0cell epitopes that are highly conserved between human and animal coronaviruses, identified from SARS-CoV-2 as targets for preemptive pan-coronavirus vaccines","volume":"206","author":"Prakash","year":"2021","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.celrep.2023.112326_bib66","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41594-021-00596-4","article-title":"Structural basis for broad coronavirus neutralization","volume":"28","author":"Sauer","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2023.112326_bib67","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cell.2020.06.035","article-title":"A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS","volume":"182","author":"Dai","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112326_bib68","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abf6840","article-title":"Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice","volume":"371","author":"Cohen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112326_bib69","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway memory CD4+ T\u00a0cells mediate protective immunity against emerging respiratory coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112326_bib70","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1080\/22221751.2021.1969291","article-title":"Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study","volume":"10","author":"Li","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.celrep.2023.112326_bib71","article-title":"Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK","author":"Pouwels","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.celrep.2023.112326_bib72","article-title":"Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence","author":"Puranik","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.celrep.2023.112326_bib73","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.15585\/mmwr.mm7037e1","article-title":"Monitoring incidence of COVID-19 cases, hospitalizations, and deaths, by vaccination status \u2014 13\u00a0U.S. Jurisdictions, april 4\u2013july 17, 2021","volume":"70","author":"Scobie","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.celrep.2023.112326_bib74","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3390\/microorganisms9081643","article-title":"Cross-reactive immune responses toward the common cold human coronaviruses and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): mini-review and a murine study","volume":"9","author":"Sealy","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.celrep.2023.112326_bib75","doi-asserted-by":"crossref","first-page":"e70330","DOI":"10.7554\/eLife.70330","article-title":"Cross-reactive antibodies after SARS-CoV-2 infection and vaccination","volume":"10","author":"Grobben","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.celrep.2023.112326_bib76","doi-asserted-by":"crossref","first-page":"eabe9950","DOI":"10.1126\/sciimmunol.abe9950","article-title":"Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers","volume":"6","author":"Klompus","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2023.112326_bib77","doi-asserted-by":"crossref","first-page":"eabq3773","DOI":"10.1126\/science.abq3773","article-title":"Broadly neutralizing antibodies target the coronavirus fusion peptide","volume":"377","author":"Dacon","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2023.112326_bib78","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1432-2277.2009.00927.x","article-title":"The aging of the immune system","volume":"22","author":"Weiskopf","year":"2009","journal-title":"Transpl. Int."},{"key":"10.1016\/j.celrep.2023.112326_bib79","first-page":"425","article-title":"Age-dependent alterations of Fc gamma receptor-mediated effector functions of human polymorphonuclear leucocytes","volume":"61","author":"F\u00fcl\u00f6p","year":"1985","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.celrep.2023.112326_bib80","doi-asserted-by":"crossref","first-page":"e00653-20","DOI":"10.1128\/IAI.00653-20","article-title":"Older but not wiser: the age-driven changes in neutrophil responses during pulmonary infections","volume":"89","author":"Simmons","year":"2021","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2023.112326_bib81","doi-asserted-by":"crossref","first-page":"e200026","DOI":"10.20900\/immunometab20200026","article-title":"Macrophage immunometabolism and inflammaging: roles of mitochondrial dysfunction, cellular senescence, CD38, and NAD","volume":"2","author":"Yarbro","year":"2020","journal-title":"Immunometabolism"},{"key":"10.1016\/j.celrep.2023.112326_bib82","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1556\/EuJMI-D-14-00035","article-title":"Ageing and the immune system: focus on macrophages","volume":"5","author":"Linehan","year":"2015","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"10.1016\/j.celrep.2023.112326_bib83","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/ncb437","article-title":"The mouse ascending: perspectives for human-disease models","volume":"9","author":"Rosenthal","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.celrep.2023.112326_bib84","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","article-title":"A mouse model of SARS-CoV-2 infection and pathogenesis","volume":"28","author":"Sun","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112326_bib85","doi-asserted-by":"crossref","first-page":"16226","DOI":"10.1038\/nmicrobiol.2016.226","article-title":"A mouse model for MERS coronavirus-induced acute respiratory distress syndrome","volume":"2","author":"Cockrell","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.celrep.2023.112326_bib86","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1128\/JVI.02298-12","article-title":"An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection","volume":"87","author":"White","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112326_bib87","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/15216540212657","article-title":"Alphavirus replicon particles as candidate HIV vaccines","volume":"53","author":"Davis","year":"2002","journal-title":"IUBMB Life"},{"key":"10.1016\/j.celrep.2023.112326_bib88","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1128\/CVI.00258-12","article-title":"Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults","volume":"19","author":"Wecker","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.celrep.2023.112326_bib89","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.3390\/v6062392","article-title":"Alphavirus-based vaccines","volume":"6","author":"Lundstrom","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.celrep.2023.112326_bib90","doi-asserted-by":"crossref","first-page":"eabm3151","DOI":"10.1126\/scitranslmed.abm3151","article-title":"Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection","volume":"14","author":"Dias","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2023.112326_bib91","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2015.06.026","article-title":"Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy","volume":"162","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112326_bib92","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1074\/jbc.M116.767749","article-title":"Effector-attenuating substitutions that maintain antibody stability and reduce toxicity in mice","volume":"292","author":"Lo","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.celrep.2023.112326_bib93","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.immuni.2017.07.009","article-title":"Fc\u03b3 receptor function and the design of vaccination strategies","volume":"47","author":"Bournazos","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2023.112326_bib94","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2015.04.016","article-title":"Differential Fc-receptor engagement drives an anti-tumor vaccinal effect","volume":"161","author":"DiLillo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112326_bib95","doi-asserted-by":"crossref","first-page":"e1005504","DOI":"10.1371\/journal.pgen.1005504","article-title":"Genome wide identification of SARS-CoV susceptibility loci using the collaborative cross","volume":"11","author":"Gralinski","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.celrep.2023.112326_bib96","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.chom.2019.03.009","article-title":"The collaborative cross: a systems genetics resource for studying host-pathogen interactions","volume":"25","author":"Noll","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2023.112326_bib97","doi-asserted-by":"crossref","first-page":"26915","DOI":"10.1073\/pnas.2001046117","article-title":"Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection","volume":"117","author":"Edwards","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2023.112326_bib98","doi-asserted-by":"crossref","first-page":"e0097421","DOI":"10.1128\/JVI.00974-21","article-title":"Protective efficacy of rhesus Adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2","volume":"95","author":"Tostanoski","year":"2021","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2023.112326_bib99","doi-asserted-by":"crossref","first-page":"eabm3410","DOI":"10.1126\/scitranslmed.abm3410","article-title":"Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice","volume":"14","author":"Sch\u00e4fer","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2023.112326_bib100","article-title":"Fc\u03b3 receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2","author":"Mackin","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2023.112326_bib101","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","article-title":"SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract","volume":"182","author":"Hou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2023.112326_bib102","doi-asserted-by":"crossref","first-page":"e0265816","DOI":"10.1371\/journal.pone.0265816","article-title":"Finding the infectious dose for COVID-19 by applying an airborne-transmission model to superspreader events","volume":"17","author":"Prentiss","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2023.112326_bib103","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2017.01.010","article-title":"Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles","volume":"443","author":"Brown","year":"2017","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.celrep.2023.112326_bib104","doi-asserted-by":"crossref","first-page":"eaat7796","DOI":"10.1126\/sciimmunol.aat7796","article-title":"Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement","volume":"3","author":"Lofano","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.celrep.2023.112326_bib105","doi-asserted-by":"crossref","first-page":"110336","DOI":"10.1016\/j.celrep.2022.110336","article-title":"SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people","volume":"38","author":"Narowski","year":"2022","journal-title":"Cell Rep."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723003376?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124723003376?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T11:44:06Z","timestamp":1762602246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124723003376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2211124723003376"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112326","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.11.28.518175","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2023.112326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"112326"}}